Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells

Leukemia

Volumn 10, Issue 3, 1996, Pages 528-542

  Steelman, L S ^a   Algate, P A ^a,b   Blalock, W L ^a   Wang, X Y ^a   Prevost, K D ^a   Hoyle, P E ^a   McCubrey, J A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b USA   (United States)

Author keywords

Cytokines; IL 3; Oncogenes; Transformation receptors

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HEMATOPOIETIC CELL; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030005128     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64. 271-280.
2. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990; 59: 783-836.
3. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotential hemopoietic cell line in the absence of added growth factors. Cell 1993; 74: 823-832.
4. Palaszynski EW, Ihle JN. Evidence for specific receptors for IL-3 on lymphokine dependent cell lines established from long-term bone marrow cultures. J Immunol 1984; 132: 1872-1878.
5. Nicola NA, Peterson L. Identification of distinct receptors for two hemopoietic growth factors (granulocyte colony-stimulating factor and multipotential colony-stimulating factor) by chemical cross-linking. J Biol Chem 1986; 261: 12384-12389.
6. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K-L. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
7. Sakamaki K, Miyajima I, Kitamura T, Miyajima A. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth, signal transduction and tyrosine phosphorylation. EMBO J 1992; 11: 3541-3549.
8. Duronio V, Clark-Lewis I, Federsppiel B, Wieler JS, Schrader JW. Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony stimulating factor. J Biol Chem 1992; 267: 21856-21863.
9. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. TIBS 1994: 19: 222-227.
10. Schreurs J, Arai K-I, Miyajima A. Evidence for a low-affinity interleukin-3 receptor. Growth Factors 1990; 2: 221-234.
11. Itoh N, Yonehara S, Schreurs J, Gorman DM, Maruyama K, Yahara I, Arai K-I, Miyajima A. Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science 1990; 247: 324-327.
12. Schreurs J, Hung P, May WS, Arai K-I, Miyajima A. AlC2A is a component of the purified high affinity mouse interleukin-3 receptors; temperature-dependent modulation of AlC2A structure. Int Immunol 1991; 3: 1231-1242.
13. Gorman DM, Itoh M, Kitamara T, Schreurs J, Yonehara S, Yahara I, Arai K-I, Miyajima A. Cloning and expression or a gene encoding an interleukin-3 receptor-like protein: identification of another member of the cytokine receptor gene family. Proc Natl Acad Sci USA 1990; 87. 5459-5463.
14. Ogorochi T, Hara T, Wang HM, Maruyama K, Miyajima A. Monoclonal antibodies specific for low-affinity interleukin-3 (IL-3) binding protein AlC2A: evidence that AlC2A is a component of a high-affinity IL-3 receptor. Blood 1992; 79: 895-903.
15. Hara T, Miyajima A. Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3). EMBO J 1992; 11: 1875-1884.
16. Takaki S, Mita S, Kitamura T, Yonehara S, Yamaguchi N, Tominaga A, Miyajima A, Takatsu K. Identification of the second subunit of the murine interleukin-5 receptor: interleukin-3 receptor-like protein, AlC2B, is a component of the high affinity interleukin-5 receptor. EMBO J 1991; 10: 2833-2838.
17. Devos R, Plaetinck G, Van der Heyden J, Cornelis S, Vandekerckhove J, Fiers W, Tavernier J. Molecular basis of a high affinity murine interleukin-5 receptor. EMBO J 1991; 10: 2133-2137.
18. Miyajima A, Mui ALF, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5. Blood 1993; 82: 1960-1974.
19. Hayashida K, Kitamura T, Gorman DM, Arai K-I, Yokota T, Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990; 87: 9655-9659.
20. Kitamura T, Hayashida K, Sakamaki K, Yokata T, Arai K-I, Miyajima A. Reconstitution of functional receptors for human granulocyte macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AlC2B cDNA is a subunit of the murine GM-CSF receptor. Proc Natl Acad Sci USA 1991; 88: 5082-5086.
21. Kitamura T, Sato M, Arai K-I, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165-1174.
22. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A. Critical cytoplasmic domains of the common beta subunit responsible for differentiation. EMBO J 1993; 12: 4181-4189.
23. Kinoshita T, Yokota T, Arai K, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J 1995; 14: 266-275.
24. Gorman DM, Itoh N, Jenkins NA, Gilbert DJ, Copeland NG, Miyajima A. Chromosomal localization and organization of the murine genes encoding the β-subunits (AlC2A and AlC2B) of the interleukin 3, granulocyte/macrophage colony-stimulating factor, and interleukin 5 receptors. J Biol Chem 1992; 267: 15842-15848.
25. Hallek M, Lepisto EM, Slattery KE, Griffin ID, Ernst TJ. Interferon-γ increases the expression of the gene encoding the β subunit of the granulocyte-macrophage colony-stimulating factor receptors. Blood 1992; 80: 1736-1742.
26. c by IL-1 and tumor necrosis factor-α. Blood 1992; 80. 2215-2220.
27. Liboi E, Jubinsky P, Andrews NC, Nathan DG, Mathey-Prevot B. Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factors. Blood 1992; 80: 1183-1189.
28. Algate PA, Steelman LS, Mayo MW, Miyajima A, McCubrey JA. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. Blood 1994; 83: 2450-2468.
29. Yue X, Favot P, Dunn TL, Cassady AI, Hume DA. Expression of mRNA encoding the macrophage colony stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol 1993; 13: 3191-3201.
30. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D. Growth factor-dependent hemopoietic precursor cell lines. J Exp Med 1980; 152: 1036-1047.
31. McKearn JP, McCubrey JA, Fagg B. Enrichment of hematopoietic precursor cells and cloning of multi-potential B lymphocyte precursors. Proc Natl Acad Sci USA 1985; 82: 7414-7418.
32. Palacios R, Steinmetz M. IL-3 dependent mouse clones that express B-220 surface antigens, contain Ig genes in germline configuration, and generate B lymphocytes in vivo. Cell 1985; 41: 727-734.
33. McCubrey J, Holland G, McKearn J, Risser R. Abrogation of factor-dependence in two IL3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res 1989; 4: 97-109.
34. McCubrey JA, Smith SR, Algate PA, DeVente JE, White MK, Steelman LS. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene 1993; 8: 2905-2915.
35. McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M. Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates IL3-dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 1991; 78: 921-929.
36. McCubrey JA, Steelman LS, Wang X-Y, Algate PA, Hoyle PE, White C, Davidian EW, Prevost KD, Robbins P, Mylott D, White MK. Differential effects of viral and cellular oncogenes on the growth factor dependency of hematopoietic cells. Int J Oncol 1995; 7: 295-310.
37. Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 1985; 41: 677-683.
38. Wheeler EF, Askew D, May S, Ihle JN, Scheer CJ. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent cell line FDC-P1. Mol Cell Biol 1987; 7: 1673-1680.
39. Pierce JH, Ruggiero M, Fleming TP, DiFiore PP, Greenberger JS, Varticovski L, Schlessinger J, Rovera C, Aaronson SA. Signal transduction through the EGF receptor transfected in IL-3 dependent hematopoietic cells. Science 1988; 239: 628-631.
40. Danial NN, Pernis A, Rothman PB. Jak-STAT signaling induced by the v-abl oncogene Science 1995; 269: 1875-1877.
41. Algate PA, McCubrey JA. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after IAP transposition. Oncogene 1993; 8: 1921-1932.
42. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences Nature 1984; 307: 521-527.
43. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665-676.
44. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988; 55: 185-192.
45. Souyri M, Vignon I, Penciolelli J-F, Heard J-M, Tambourin P, Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137-1147.
46. de Sauvage FJ, Mass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
47. D'Andrea R, Rayner J, Moretti P, Lopez A, Goodall GJ, Gonda TJ, Vadas M. A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity. Blood 1994; 83: 2802-2808.
48. c subunit. Mol Cell Biol 1994; 15: 2402-2412.
49. Ichihara M, Hara T, Takagi M, Cho LC, Gorman DM, Miyajima A Impaired interleukin-3 (IL-3) response of the A/J mouse is caused by a branch point deletion in the IL-3 receptor α subunit gene. EMBO J 1995; 14: 939-950.
50. Nori M, Shawver LK, Weber MJ. A swiss 3T3 variant cell line resistant to the effects of tumor promoters cannot be transformed by src. Mol Cell Biol 1990; 10: 4155-4162.
51. Schwartz RC, Stanton LW, Riley SC, Marcu KB, Witte ON. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol 1986; 6: 3321-3331.
52. Daley GQ, Baltimore D. Transformation of an interleukin-3 dependent hematopoietic cells line by the chronic myelogenous leukemia-specific p210 BCR-ABL protein. Proc Natl Acad Sci USA 1988; 85: 9312-9316.
53. Samuels ML, Weber MJ, Bishop JM, McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 1993; 13: 6241-6252.
54. Miller AD, Rosman CJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
55. McCubrey JA, Steelman LS, McKearn JP. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interieukin-3 dependent cell line. Oncogene Res 1991; 6: 1-12.
56. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
57. Fung MC, Hapel AJ, Ymer S, Cohen DR, Johnson RM, Campbell HD, Young IG. Molecular cloning of cDNA for murine interleukin-3. Nature 1984; 307: 233-237.
58. McCubrey JA, Algate PA, Mayo MW, Arana G, Wang XY, Prevost KD, White MK, Steelman LS. Differential effects of tumor promoters and cytokines on proto-oncogene expression in a hematopoietic cytokine-dependent cell line. Oncol Rep 1994; 1: 285-300.
59. Ymer S, Tucker WQJ, Sanderson CJ, Hapel AJ, Cambell HD, Young IG. Constitutive synthesis of interleukin-3 by leukemia-cell line is due to retroviral insertion near the gene. Nature 1985; 317: 225-228.
60. Mayo MW, Wang XY, Algate PA, Arana GF, Hoyle PE, Steelman LS, McCubrey JA. Synergy between AUUUA motif disruption and enhancer insertion result in autocrine transformation of interleukin-3 dependent hematopoietic cells. Blood 1995; 86: 3139-3151.
61. Kuff EL, Lueders KK. The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Res 1988; 51: 183-276.
62. Christy RJ, Huang RCC. Functional analysis of the long terminal repeats of intracisternal A-particle genes: sequences within the U3 region determine both the efficiency and direction of promoter activity. Mol Cell Biol 1988; 8: 1093-1102.
63. Lueders KK, Fewell JW, Morozov VE, Kuff E. Selective expression of intracisternal A-particle genes in established mouse plasmacytomas. Mol Cell Biol 1993; 13: 7439-7446.
64. Hara T, Miyajima A. Regulation of IL-3 receptor expression: evidence for a post-transcriptional mechanism that dominantly suppresses the expression of β-subunits. Int Immunol 1994, 6: 1525-1533.
65. Welham MJ, Schrader JW. Modulation of c-kit mRNA and protein by hemopoietic growth factors. Mol Cell Biol 1991; 11: 2901-2904.
66. Gliniak BC, Rohrschneider LR. Expression of the M-CSF receptor is controlled post-transcriptionally by the dominant actions of GM-CSF or multi-CSF. Cell 1990; 63: 1073-1083.